SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Evolutionary Genomics, Inc. – ‘10-Q’ for 9/30/19 – ‘EX-101.CAL’

On:  Thursday, 10/17/19, at 1:05pm ET   ·   For:  9/30/19   ·   Accession #:  1553350-19-1065   ·   File #:  0-54129

Previous ‘10-Q’:  ‘10-Q’ on 8/12/19 for 6/30/19   ·   Next:  ‘10-Q’ on 5/12/20 for 3/31/20   ·   Latest:  ‘10-Q’ on 10/21/22 for 9/30/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/17/19  Evolutionary Genomics, Inc.       10-Q        9/30/19   52:2.4M                                   Edgar Filing LLC/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    355K 
 2: EX-31.1     Certifications                                      HTML     20K 
 3: EX-31.1     Certifications                                      HTML     20K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
46: R1          Document and Entity Information                     HTML     48K 
31: R2          Condensed and Consolidated Balance Sheets           HTML     91K 
15: R3          Condensed and Consolidated Balance Sheets           HTML     41K 
                (Parenthetical)                                                  
41: R4          Condensed and Consolidated Statements of            HTML     58K 
                Operations                                                       
45: R5          Condensed and Consolidated Statement of             HTML     46K 
                Stockholders' Equity                                             
30: R6          Condensed and Consolidated Statements of Cash       HTML     63K 
                Flows                                                            
14: R7          Business Activity                                   HTML     23K 
40: R8          Summary of Significant Accounting Policies          HTML     32K 
47: R9          New Accounting Standards                            HTML     22K 
18: R10         Fair Value Measurements                             HTML     39K 
25: R11         Property and Equipment                              HTML     28K 
52: R12         Intangible Assets                                   HTML     27K 
36: R13         Stockholders' Equity and Warrants                   HTML     43K 
17: R14         Stock-Based Compensation                            HTML     60K 
24: R15         Commitments and Contingencies                       HTML     23K 
51: R16         Related Parties and Transactions                    HTML     19K 
35: R17         Concentrations                                      HTML     19K 
19: R18         Liquidity and Going Concern                         HTML     23K 
23: R19         Summary of Significant Accounting Policies          HTML     73K 
                (Policies)                                                       
44: R20         Fair Value Measurements (Tables)                    HTML     35K 
38: R21         Property and Equipment (Tables)                     HTML     27K 
13: R22         Intangible Assets (Tables)                          HTML     25K 
29: R23         Stockholders' Equity and Warrants (Tables)          HTML     38K 
43: R24         Stock-Based Compensation (Tables)                   HTML     59K 
37: R25         Business Activity (Details)                         HTML     18K 
11: R26         Summary of Significant Accounting Policies (Other)  HTML     24K 
                (Details)                                                        
28: R27         Summary of Significant Accounting Policies          HTML     21K 
                (Property and Equipment) (Details)                               
42: R28         Summary of Significant Accounting Policies          HTML     20K 
                (Intangible Assets) (Details)                                    
39: R29         Summary of Significant Accounting Policies (Net     HTML     26K 
                Loss Per Common Share) (Details)                                 
33: R30         Fair Value Measurements (Details)                   HTML     29K 
48: R31         Property and Equipment (Details)                    HTML     36K 
26: R32         Intangible Assets (Details)                         HTML     48K 
20: R33         Stockholders' Equity and Warrants (Narrative)       HTML     43K 
                (Details)                                                        
34: R34         Stockholders' Equity and Warrants (Summary of       HTML     41K 
                Warrants Activity) (Details)                                     
49: R35         Stock-Based Compensation (Narrative) (Details)      HTML     32K 
27: R36         Stock-Based Compensation (Summary of Stock Options  HTML     57K 
                Activity) (Details)                                              
21: R37         Commitments and Contingencies (Details)             HTML     28K 
32: R38         Related Parties and Transactions (Details)          HTML     21K 
50: R39         Liquidity and Going Concern (Details)               HTML     42K 
22: XML         IDEA XML File -- Filing Summary                      XML     90K 
16: EXCEL       IDEA Workbook of Financial Reports                  XLSX     42K 
 5: EX-101.INS  XBRL Instance -- fnam-20190930                       XML    687K 
 7: EX-101.CAL  XBRL Calculations -- fnam-20190930_cal               XML    101K 
 8: EX-101.DEF  XBRL Definitions -- fnam-20190930_def                XML    223K 
 9: EX-101.LAB  XBRL Labels -- fnam-20190930_lab                     XML    528K 
10: EX-101.PRE  XBRL Presentations -- fnam-20190930_pre              XML    398K 
 6: EX-101.SCH  XBRL Schema -- fnam-20190930                         XSD     84K 
12: ZIP         XBRL Zipped Folder -- 0001553350-19-001065-xbrl      Zip     66K 


‘EX-101.CAL’   —   XBRL Calculations — fnam-20190930_cal


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" standalone="no" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.1b -->
<!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
<!-- Field: Doc-Info; Name: Source; Value: Evolutionary Genomics, Inc. 9%2D30%2D19 10Q.xfr; Date: 2019%2D10%2D17T15:23:49Z -->
<!-- Field: Doc-Info; Name: Status; Value: 0x800B0000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/fnam-daei" xlink:href="fnam-20190930.xsd#fnam-daei" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/AndConsolidatedBalanceSheets" xlink:href="fnam-20190930.xsd#AndConsolidatedBalanceSheets" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/AndConsolidatedBalanceSheetsParenthetical" xlink:href="fnam-20190930.xsd#AndConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/AndConsolidatedStatementsOfOperations" xlink:href="fnam-20190930.xsd#AndConsolidatedStatementsOfOperations" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/AndConsolidatedStatementOfStockholdersEquity" xlink:href="fnam-20190930.xsd#AndConsolidatedStatementOfStockholdersEquity" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/AndConsolidatedStatementsOfCashFlows" xlink:href="fnam-20190930.xsd#AndConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/NatureOfBusiness" xlink:href="fnam-20190930.xsd#NatureOfBusiness" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fnam-20190930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/NewAccountingStandards" xlink:href="fnam-20190930.xsd#NewAccountingStandards" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/FairValueMeasurements" xlink:href="fnam-20190930.xsd#FairValueMeasurements" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/PropertyAndEquipment" xlink:href="fnam-20190930.xsd#PropertyAndEquipment" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/IntangibleAssets" xlink:href="fnam-20190930.xsd#IntangibleAssets" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/Disclosure-CommonStock" xlink:href="fnam-20190930.xsd#Disclosure-CommonStock" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/Stock-basedCompensation" xlink:href="fnam-20190930.xsd#Stock-basedCompensation" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/CommitmentsAndContingencies" xlink:href="fnam-20190930.xsd#CommitmentsAndContingencies" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/RelatedPartiesAndTransactions" xlink:href="fnam-20190930.xsd#RelatedPartiesAndTransactions" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/Concentrations" xlink:href="fnam-20190930.xsd#Concentrations" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/LiquidityAndGoingConcern" xlink:href="fnam-20190930.xsd#LiquidityAndGoingConcern" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/fnam-se" xlink:href="fnam-20190930.xsd#fnam-se" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/fnam-soapadobp" xlink:href="fnam-20190930.xsd#fnam-soapadobp" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/FairValueMeasurementsTables" xlink:href="fnam-20190930.xsd#FairValueMeasurementsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/PropertyAndEquipmentTables" xlink:href="fnam-20190930.xsd#PropertyAndEquipmentTables" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/IntangibleAssetsTables" xlink:href="fnam-20190930.xsd#IntangibleAssetsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/StockholdersEquityAndWarrantsTables" xlink:href="fnam-20190930.xsd#StockholdersEquityAndWarrantsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/Stock-basedCompensationTables" xlink:href="fnam-20190930.xsd#Stock-basedCompensationTables" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/BusinessActivityDetails" xlink:href="fnam-20190930.xsd#BusinessActivityDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesOtherDetails" xlink:href="fnam-20190930.xsd#SummaryOfSignificantAccountingPoliciesOtherDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:href="fnam-20190930.xsd#SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesIntangilbeAssetsDetails" xlink:href="fnam-20190930.xsd#SummaryOfSignificantAccountingPoliciesIntangilbeAssetsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" xlink:href="fnam-20190930.xsd#SummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/FairValueMeasurementsDetails" xlink:href="fnam-20190930.xsd#FairValueMeasurementsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/PropertyAndEquipmentDetails" xlink:href="fnam-20190930.xsd#PropertyAndEquipmentDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/IntangibleAssetsDetails" xlink:href="fnam-20190930.xsd#IntangibleAssetsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/Disclosure-CommonStockDetails" xlink:href="fnam-20190930.xsd#Disclosure-CommonStockDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/StockholdersEquityAndWarrantsSummaryOfWarrantsActivityDetails" xlink:href="fnam-20190930.xsd#StockholdersEquityAndWarrantsSummaryOfWarrantsActivityDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/Stock-basedCompensationNarrativeDetails" xlink:href="fnam-20190930.xsd#Stock-basedCompensationNarrativeDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/Stock-basedCompensationSummaryOfStockOptionsActivityDetails" xlink:href="fnam-20190930.xsd#Stock-basedCompensationSummaryOfStockOptionsActivityDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/CommitmentsAndContingenciesDetails" xlink:href="fnam-20190930.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/RelatedPartiesAndTransactionsDetails" xlink:href="fnam-20190930.xsd#RelatedPartiesAndTransactionsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://evolutionarygenomicsinc.com/role/LiquidityAndGoingConcernDetails" xlink:href="fnam-20190930.xsd#LiquidityAndGoingConcernDetails" xlink:type="simple"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/fnam-daei" xlink:title="00000001 - Document - Document and Entity Information"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/AndConsolidatedBalanceSheets" xlink:title="00000002 - Statement - Condensed and Consolidated Balance Sheets">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredTaxLiabilitiesNoncurrent"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/AndConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed and Consolidated Balance Sheets (Parenthetical)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/AndConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - Condensed and Consolidated Statements of Operations">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" weight="-1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/AndConsolidatedStatementOfStockholdersEquity" xlink:title="00000005 - Statement - Condensed and Consolidated Statement of Stockholders' Equity"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/AndConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed and Consolidated Statements of Cash Flows">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:label="loc_us-gaapPaymentsToAcquireTradingSecuritiesHeldforinvestment"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/NatureOfBusiness" xlink:title="00000007 - Disclosure - Business Activity"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/NewAccountingStandards" xlink:title="00000009 - Disclosure - New Accounting Standards"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/FairValueMeasurements" xlink:title="00000010 - Disclosure - Fair Value Measurements"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/PropertyAndEquipment" xlink:title="00000011 - Disclosure - Property and Equipment"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/IntangibleAssets" xlink:title="00000012 - Disclosure - Intangible Assets"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/Disclosure-CommonStock" xlink:title="00000013 - Disclosure - Stockholders' Equity and Warrants"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/Stock-basedCompensation" xlink:title="00000014 - Disclosure - Stock-Based Compensation"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - Commitments and Contingencies"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/RelatedPartiesAndTransactions" xlink:title="00000016 - Disclosure - Related Parties and Transactions"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/Concentrations" xlink:title="00000017 - Disclosure - Concentrations"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/LiquidityAndGoingConcern" xlink:title="00000018 - Disclosure - Liquidity and Going Concern"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/fnam-se" xlink:title="00000019 - Disclosure - Subsequent Events"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/fnam-soapadobp" xlink:title="00000020 - Disclosure - Summary of Significant Accounting Policies (Policies)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/FairValueMeasurementsTables" xlink:title="00000021 - Disclosure - Fair Value Measurements (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/PropertyAndEquipmentTables" xlink:title="00000022 - Disclosure - Property and Equipment (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/IntangibleAssetsTables" xlink:title="00000023 - Disclosure - Intangible Assets (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/StockholdersEquityAndWarrantsTables" xlink:title="00000024 - Disclosure - Stockholders' Equity and Warrants (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/Stock-basedCompensationTables" xlink:title="00000025 - Disclosure - Stock-Based Compensation (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/BusinessActivityDetails" xlink:title="00000026 - Disclosure - Business Activity (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesOtherDetails" xlink:title="00000027 - Disclosure - Summary of Significant Accounting Policies (Other) (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:title="00000028 - Disclosure - Summary of Significant Accounting Policies (Property and Equipment) (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesIntangilbeAssetsDetails" xlink:title="00000029 - Disclosure - Summary of Significant Accounting Policies (Intangible Assets) (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/SummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" xlink:title="00000030 - Disclosure - Summary of Significant Accounting Policies (Net Loss Per Common Share) (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/FairValueMeasurementsDetails" xlink:title="00000031 - Disclosure - Fair Value Measurements (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsFairValueDisclosure" xlink:to="loc_us-gaapInvestments" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/PropertyAndEquipmentDetails" xlink:title="00000032 - Disclosure - Property and Equipment (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/IntangibleAssetsDetails" xlink:title="00000033 - Disclosure - Intangible Assets (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/Disclosure-CommonStockDetails" xlink:title="00000034 - Disclosure - Stockholders' Equity and Warrants (Narrative) (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/StockholdersEquityAndWarrantsSummaryOfWarrantsActivityDetails" xlink:title="00000035 - Disclosure - Stockholders' Equity and Warrants (Summary of Warrants Activity) (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/Stock-basedCompensationNarrativeDetails" xlink:title="00000036 - Disclosure - Stock-Based Compensation (Narrative) (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/Stock-basedCompensationSummaryOfStockOptionsActivityDetails" xlink:title="00000037 - Disclosure - Stock-Based Compensation (Summary of Stock Options Activity) (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000038 - Disclosure - Commitments and Contingencies (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/RelatedPartiesAndTransactionsDetails" xlink:title="00000039 - Disclosure - Related Parties and Transactions (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://evolutionarygenomicsinc.com/role/LiquidityAndGoingConcernDetails" xlink:title="00000040 - Disclosure - Liquidity and Going Concern (Details)"/>
</link:linkbase>

Top
Filing Submission 0001553350-19-001065   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 1:05:11.1am ET